国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Aquifex aeolicus 50S ribosomal protein L20 (rplT) CSB-YP524722DNV
CSB-EP524722DNV
CSB-BP524722DNV
CSB-MP524722DNV
CSB-EP524722DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Arginine biosynthesis bifunctional protein ArgJ (argJ) CSB-YP524723DNV
CSB-EP524723DNV
CSB-BP524723DNV
CSB-MP524723DNV
CSB-EP524723DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Tryptophan--tRNA ligase (trpS) CSB-YP524724DNV
CSB-EP524724DNV
CSB-BP524724DNV
CSB-MP524724DNV
CSB-EP524724DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Uncharacterized protein aq_1022 (aq_1022) CSB-YP524725DNV
CSB-EP524725DNV
CSB-BP524725DNV
CSB-MP524725DNV
CSB-EP524725DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Glycine cleavage system H protein 1 (gcvH1) CSB-YP524726DNV
CSB-EP524726DNV
CSB-BP524726DNV
CSB-MP524726DNV
CSB-EP524726DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Ribosome maturation factor RimM (rimM) CSB-YP524727DNV
CSB-EP524727DNV
CSB-BP524727DNV
CSB-MP524727DNV
CSB-EP524727DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP524728DNV
CSB-EP524728DNV
CSB-BP524728DNV
CSB-MP524728DNV
CSB-EP524728DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Phosphoribosylformylglycinamidine synthase 1 (purQ) CSB-YP524729DNV
CSB-EP524729DNV
CSB-BP524729DNV
CSB-MP524729DNV
CSB-EP524729DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus S-adenosylmethionine synthase (metK) CSB-YP524730DNV
CSB-EP524730DNV
CSB-BP524730DNV
CSB-MP524730DNV
CSB-EP524730DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Flagellar M-ring protein (fliF), partial CSB-YP524731DNV1
CSB-EP524731DNV1
CSB-BP524731DNV1
CSB-MP524731DNV1
CSB-EP524731DNV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Flagellar biosynthesis protein flhA (flhA), partial CSB-YP524732DNV
CSB-EP524732DNV
CSB-BP524732DNV
CSB-MP524732DNV
CSB-EP524732DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Probable S-adenosylmethionine synthase (mat) CSB-YP524733DNV
CSB-EP524733DNV
CSB-BP524733DNV
CSB-MP524733DNV
CSB-EP524733DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Undecaprenyl pyrophosphate synthase (uppS) CSB-YP524734DNV
CSB-EP524734DNV
CSB-BP524734DNV
CSB-MP524734DNV
CSB-EP524734DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Carbon starvation protein A homolog (cstA), partial CSB-YP524735DNV
CSB-EP524735DNV
CSB-BP524735DNV
CSB-MP524735DNV
CSB-EP524735DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP524736DNV
CSB-EP524736DNV
CSB-BP524736DNV
CSB-MP524736DNV
CSB-EP524736DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP524737DNV
CSB-EP524737DNV
CSB-BP524737DNV
CSB-MP524737DNV
CSB-EP524737DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus NADH-quinone oxidoreductase subunit N 1 (nuoN1), partial CSB-YP524738DNV
CSB-EP524738DNV
CSB-BP524738DNV
CSB-MP524738DNV
CSB-EP524738DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Probable rRNA maturation factor (aq_1354) CSB-YP524739DNV
CSB-EP524739DNV
CSB-BP524739DNV
CSB-MP524739DNV
CSB-EP524739DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Valine--tRNA ligase (valS), partial CSB-YP524740DNV
CSB-EP524740DNV
CSB-BP524740DNV
CSB-MP524740DNV
CSB-EP524740DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aquifex aeolicus Protein aq_1444 (aq_1444) CSB-YP524741DNV
CSB-EP524741DNV
CSB-BP524741DNV
CSB-MP524741DNV
CSB-EP524741DNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>